The purpose of this research is to collect the magnetic signals from the heart to identify features that may help Emergency Department (ED) doctors differentia…

Acute Coronary Syndromes (ACS)Coronary Artery Disease (CAD)Chest Pain+1 more

~Estimated

~$10 – $1,050

SB Technology, Inc.NCT07822581

Phase 1

A Pivotal Comparative Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of CG-0255 Besylate and Plavix® in Healthy Participants

CG-0255 is a novel investigational prodrug of the active metabolite of Plavix®， but with different active metabolite conversion routes. This is a randomized, o…

Acute Coronary Syndromes (ACS)Recent Myocardial InfarctionRecent Stroke+1 more

~Estimated

~$10 – $8,750

Shanghai CureGene Pharmaceutical Co., Ltd.NCT07619885

Phase 2

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Orticumab in Participants With Prior Myocardial Infarction Who Have Elevated Coronary Inflammation Based on FAI Score Assessed by CCTA

The goal of this clinical trial is to determine the clinical effect of orticumab treatment on inflammation in study participants with prior myocardial infarcti…

Acute Coronary SyndromesCoronary Arterial Disease (CAD)Inflammation+3 more

~Estimated

~$10 – $7,500

AbcentraNCT06927739